Authors: Stowers, AW Zhang, YL Shimp, RL Kaslow, DC

Citation: Aw. Stowers et al., Structural conformers produced during malaria vaccine production in yeast, YEAST, 18(2), 2001, pp. 137-150

Authors: Kedzierski, L Black, CG Stowers, AW Goschnick, MW Kaslow, DC Coppel, RL

Citation: L. Kedzierski et al., Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii, VACCINE, 19(32), 2001, pp. 4661-4668

Authors: Stowers, AW Cioce, V Shimp, RL Lawson, M Hui, G Muratova, O Kaslow, DC Robinson, R Long, CA Miller, LH

Citation: Aw. Stowers et al., Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial, INFEC IMMUN, 69(3), 2001, pp. 1536-1546

Authors: Hisaeda, H Stowers, AW Tsuboi, T Collins, WE Sattabongkot, JS Suwanabun, N Torii, M Kaslow, DC

Citation: H. Hisaeda et al., Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes, INFEC IMMUN, 68(12), 2000, pp. 6618-6623

Authors: Stowers, AW Keister, DB Muratova, O Kaslow, DC

Citation: Aw. Stowers et al., A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies, INFEC IMMUN, 68(10), 2000, pp. 5530-5538